Skip to main content

Prevalence and influencing factors of self-medication during the COVID-19 pandemic in the Arab region: a multinational cross-sectional study



The novel coronavirus pandemic (COVID-19) has begun with a wave of misinformation and fear of infection. This may have led people to self-medicate inappropriately. The World Health Organization describes self-medication (SM) as utilizing medicines to relieve symptoms or health conditions without consulting a physician. Inappropriate drug use is a burden on both health resources and patient health in the Arab region. This study aimed to detect the prevalence and influencing factors of self-medication among the general Arab population during the COVID-19 pandemic.


A multinational cross-sectional study was conducted among the general population of ten Arab countries from early August to late October 2021. Participants aged 18 years or older could join the study via social media platforms. A convenience sampling technique was used. A developed and validated web-based questionnaire was used to collect data on self-medication practice, associated influencing factors, information sources, commonly used medications, and commonly treated conditions. Descriptive, univariate, and multivariate regression analyses were applied using IBM SPSS v 26 and R v 4.0.0 software.


A total of 8163 participants completed the questionnaire, and 518 participants were excluded from the analysis due to inconsistencies in their data. Almost two-thirds (62.7%) of participants reported practicing self-medication during the COVID-19 pandemic. At the country level, Egypt had the highest prevalence of self-medication practice (72.1%), while Palestine had the lowest prevalence (40.4%). The most commonly used drugs were analgesics, antipyretics, and vitamins (86, 65.1, and 57.1%, respectively), while antitussives and antibiotics scored 47.6 and 43.3%, respectively. Experience with similar health conditions (74.6%) and urgency of the problem (47.2%) were the most frequent factors that led to self-medication. Additionally, 38.2% of the self-medicated participants (SMPs) used drugs as prophylaxis against COVID-19. Pharmacist consultation was the most common source of information about self-medication (66.7%). Multivariate analysis showed that predictors of self-medication were older age (p = 0.008), presence of chronic illness (p = 0.015), and having monthly income or medical insurance that does not cover the treatment cost (p = 0.001, p < 0.001, respectively).


Self-medication is considered a common practice across the Arab population. It is necessary to regulate policies and raise awareness among the public about self-medication.

Peer Review reports


From Wuhan city in Central China’s Hubei Province, the novel coronavirus disease (COVID-19) emerged in December 2019 [1]. Subsequently, it rapidly spread to other parts of the world with rising morbidity and mortality rates [2, 3]. Then, the World Health Organization (WHO) declared it a global pandemic in March 2020 [4]. In response to this emergency, governments globally had to adopt restrictive measures such as lockdowns and social distancing. This has made access to healthcare services very challenging and has led many people to self-medicate [5]. Other factors that could have increased the practice of self-medication (SM) were people’s fear of catching the virus, the absence of definitive treatment for COVID-19, and the absence of COVID-19 vaccines during the early period of the pandemic crisis [6,7,8]. Furthermore, the misinformation circulating on social platforms has created a massive hysteria about the prevention and treatment of COVID-19; this infodemic is likely to have further increased the practice of self-medication (SM) among the general population [8, 9].

The WHO defines self-medication as “the use of medicinal products by the consumer to treat self-recognized disorders or symptoms, or the intermittent or continued use of a medication prescribed by a physician for chronic or recurring diseases or symptoms. In practice, it also includes the use of the medication of family members, especially where the treatment of children or the elderly is involved” [10]. Self-medication (SM) is a frequent behavior worldwide. Several studies have determined that the prevalence of self-medication before the COVID-19 pandemic ranged from 11.2 to 93.7% based on the studied population and country [11,12,13,14,15,16,17,18,19,20]. Google searches about SM have increased since the declaration of the COVID-19 pandemic [21]. This would imply a rise in interest in persons looking for information about self-medication to treat various illnesses.

The appropriate use of self-medication has a positive influence on patients and healthcare systems [22]. It allows patients to manage their health status, thus raising self-empowerment. It is convenient to prevent and relieve minor conditions. At the healthcare system level, it decreases wasting medical resources on minor conditions and reduces the load on healthcare services [22, 23]. This has been useful at times when healthcare systems were overwhelmed by the COVID-19 situation [22]. Furthermore, it can have economic benefits for patients, healthcare systems, and third-party payers such as governments or insurance companies [24]. However, several studies have found that improper self-medication practices can put patients at risk for serious complications such as adverse reactions, comorbidities, and increasing antimicrobial resistance, which is currently a global challenge [25,26,27,28,29]. The most common self-administered medications include painkillers, antipyretics, antidiarrheals, cough syrups, vitamins, sleeping pills, antibiotics, herbals, and home remedies [30]. Information about SM may come from family, friends, pharmacists, previous prescriptions, and the media [31]. Previous studies have shown that self-medication patterns differ from one population to another and are affected by several sociodemographic factors, including age, gender, income, education level, and medical knowledge [32,33,34,35,36].

The main objective of this study was to assess the prevalence and influencing factors of self-medication in general among the Arab general population during the COVID-19 pandemic. It also aimed to determine the most commonly self-prescribed drugs and sources of information about SM. The results of this study will inform healthcare policymakers about the proper measures that would regulate SM practices in the Arab region.


Study design and population

A multinational cross-sectional study was conducted among the general population of 10 Arab countries (Algeria, Egypt, Iraq, Jordan, Palestine, Saudi Arabia, Sudan, Oman, Syria, and Yemen) using a web-based questionnaire. Arab adults aged 18 years old or above were eligible to participate. Respondents who did not complete the questionnaire participated in the pilot phase or who responded to the questionnaire within less than 1 min were excluded.

Sample size calculation

Epi Info software version was used to estimate the sample size. It was 384 for each country at a confidence level of 95%. The investigators assumed that 50% of the population would practice self-medication with a 5% margin error.

Questionnaire development and measurement

A questionnaire was designed based on previous similar studies and literature reviews (as shown in Additional file 1) [37,38,39,40]. It was prepared in English and then translated into Arabic. We applied back translation into English again and made sure about the equivalence of the meaning. After that, a pilot study was conducted to help reveal any ambiguity before mass spreading. Three experts were reached to evaluate the clarity, comprehensiveness, and relevance of the questions to the study objectives. During the first 10 days of July 2021, participants were recruited for the pilot study to rate the clarity and relevance of the questions to the study objectives, and a total of 592 participants completed the Arabic version of the questionnaire, while 77 participants completed the questionnaire in English. The questionnaire was then edited based on the opinions of experts and the feedback from participants. The pilot study participants were not included in the final analysis.

Cronbach’s alpha test was also used to measure the reliability of the questions for both versions. The Arabic version achieved 0.708 after removing two questions, while the English version scored 0.502. The English version of the questionnaire was not used for data collection due to its poor reliability and low response rate.

The final version of the questionnaire consisted of three sections. The first section discussed information related to demographics such as age, gender, occupation, educational level, and living area. The second section assessed the prevalence of SM, which was measured by asking “Have you ever taken any medicine/drug without consulting a qualified physician?” with responses of “never which was considered NO, and coded as 0”,and “once, seldom (2-3 times a year), sometimes (once every few months), often (once every few weeks), always which were all considered Yes for SM and coded as 1). The third section included questions related to the most common drug used, for what conditions, influencing factors, and sources of information about self-medication; these were multiple choice questions, and each choice had 2 possible answers: “yes“ and “no“. each was coded as “1” and “0”, respectively. Additionally, the consumption rate of the self-medication practice was assessed in the third section (decreased, remained unchanged, or increased during the pandemic). These options were coded from 1 to 3 in order. All questions were mandatory to be answered if the participants reported that they practiced self-medication. On the other hand, the questionnaire ended automatically in the first section if a participant replied that they had never practiced self-medication.

Data collection

Social media platforms were used to recruit collaborators from 12 Arab countries who helped collect the necessary data on self-medication from the target population. A convenience sampling technique was used to recruit respondents from August 1 to October 30, 2021, and questionnaires were distributed via social media platforms to collect data on self-medication. For countries that had given their ethical approval to conduct this study, data were also collected offline to achieve the target sample size. Ten countries accomplished the required sample size (Algeria, Egypt, Iraq, Jordan, Palestine, Saudi Arabia, Sudan, Oman, Syria, and Yemen). Offline collected data were transferred to a Microsoft Excel sheet for organization prior to analysis.


The data were organized in a Microsoft Excel sheet and then exported to IBM SPSS version 26 to conduct descriptive analysis for demographics and other study variables.

The “age” variable was the only numerical one and was tested for normality using a boxplot and Shapiro test that both revealed its skewness so was described in median (minimum-maximum). A univariate and multivariate logistic regression model was used to determine the likelihood of the included factors in terms of crude and adjusted odds ratio. The dependent variable was self-medication practice during the pandemic, which was considered binomial (yes/no), and the independent variables included were selected from the very beginning based on the literature. A hierarchy approach was applied, and Hosmer–Lemeshow resulted in a p value of 0.658, indicating the goodness of model fit.


In total, 8163 participants completed the questionnaire. Egypt had the highest response rate (28.4%), while Oman had the lowest response rate (5%). Data from 518 participants were excluded from the analysis due to their inconsistency. The final analysis included data from 7645 respondents. Table 1 shows the demographic information of the participants. Most of the respondents were young adults, with a median age of 22 years, ranging from 18 to 93 years. Of them, 2638 participants (34.5%) were males, while 5007 participants (65.5%) were females. The great majority of respondents were well educated with a university education (80.5%), lived in an urban area (76.8%), were in the medical field (42.1%), did not have medical insurance (58.1%), and had a monthly income that could cover the treatment cost (63.1%) (Table 1). Almost two-thirds of the participants (62.7%) reported using drugs without a doctor’s supervision. The prevalence differs from one country to another. Egypt had the greatest prevalence (72.10%), while Palestine had the lowest prevalence of SM (40.40%) (Fig. 1).

Table 1 Demographic and characteristics of respondents (n = 7645)
Fig. 1
figure 1

Self-medication practice across the different countries

Pain killers were the most consumed drugs (86.0%), followed by fever-relieving pills, vitamins, anticoagulants, and antibiotics (65.1, 57.1, 47.6, and 43.3%, respectively) (Table 2).

Table 2 Medications used for self-medication (N = 4793)b

People tended to self-medicate when they had headaches (85.4%), flu common-cold and cough together (67.4%), and pain elsewhere (56.0%) (Table 3).

Table 3 Health conditions for which self-medication is practiced (N = 4793)

Experience with similar conditions and urgency of the case were the most common factors leading to SM (74.6 and 47.2%, respectively). A considerable number of participants practiced SM due to fear of infection (41.6%), while 38.2% were taking drugs as a prophylaxis against COVID-19 (Table 4).

Table 4 Reasons behind self-medication practice (N = 4793)

Pharmacist consultation was the most common source of information about self-prescribed medications (66.7%), followed by academic experience and prior prescription of the participant with the same frequency (50.1%) (Table 5). The consumption rate of 19.7% of people who practice self-medication increased during the pandemic, while 63.9% remained unchanged.

Table 5 Source of information about medications (N = 4793)

In a univariate model, significantly increased odds of self-medication (OR: 1.02; 95% CI: 1.01–1.02, p < 0.001) were observed with increasing age. Additionally, there was a significantly increased odds of self-medication if the participant was a governmental employee (OR: 1.47; 95% CI: 1.25–1.73, p < 0.001). Similarly, participants who had a monthly income or medical insurance, but it did not cover the treatment cost, showed significantly increased odds (OR: 1.22; 95% CI: 1.03–1.46, p = 0.024 and OR: 1.15; 95% CI: 1.03–1.29, p = 0.017, respectively) of self-medication. Furthermore, participants with chronic diseases showed significantly increased odds (OR: 1.40; 95% CI: 1.21–1.63, p < 0.001) of self-medication compared to those without chronic diseases (Table 6).

Table 6 Univariate and multivariate logistic regression analysis showing predictors of self-medication among study participantsb

In multivariate logistic regression, increasing age was also associated with a significant increase in self-medication odds (aOR: 1.01; 95% CI: 1.00–1.02, p = 0.008) having a monthly income or medical insurance that does not cover the treatment cost retained significantly increased odds with higher folds (aOR: 11.38; 95% CI: 1.15–1.66, p = 0.001 and aOR: 1.34; 95% CI: 1.17–1.52, p < 0.001, respectively). Additionally, participants with chronic diseases showed significantly increased odds (aOR: 1.22; 95% CI: 1.04–1.43, p = 0.015) of self-medication compared to those without chronic diseases (Table 6).


The uncontrolled practice of self-medication results in serious health hazards [41]. Its prevalence is high in Arab countries [42]. Many factors influence SM, including socioeconomic status, access to health care facilities, and the emergency of the condition, as previously reported [43]. The COVID-19 pandemic emphasized these factors and added fear of the infection, lockdown policies, and increased internet searches about self-medication [21]. As follows, the public became more liable to misinformation and misuse of medicines [44, 45]. This paper aimed to assess the prevalence, influencing factors of self-medication, the commonly used drugs, and the sources of information about SM among Arab countries during the COVID-19 pandemic. This study reported that self-medication practice was highly prevalent among respondents. The most commonly used drugs were analgesics, antipyretics, and vitamins. The common associated risk factors were experience with similar health conditions and the urgency of the problem. Pharmacist consultation was the most frequent source of information for self-medication. Predictors of self-medication practice were older age, having chronic diseases, and having monthly income or medical insurance that does not cover the treatment costs. It is considered the first one of its kind that included such a large sample size across the Arab region during the COVID-19 pandemic.

We found that 62.7% of the participants self-medicated during the COVID-19 pandemic; the prevalence rate ranged from 40.4% in Palestine to 72.1% in Egypt. These results differ from the findings of an earlier systematic review across the Middle East before the pandemic revealing prevalence rates ranging from 35.4% in Saudi Arabia to 83% in Iran [39]. Additionally, similar studies conducted in different countries around the world showed significant health hazards of SM [7, 46,47,48,49,50,51,52,53,54]. This study detected an increase in the consumption rate of SM during the pandemic in 19.6% of the self-medicated participants (SMPs), no change in 63.7%, and a decrease in 16.3%.

The data clarified a significant association of SM with chronic disease. Other studies revealed similar findings [55, 56]. The reason may be due to the effective use of medicines in previous similar conditions [57]. Experience with similar conditions was the most frequent reason for SM (74.6%) among SMPs. The stable character of chronic disease may also contribute to SM practice rather than visiting a physician [55]. Approximately 41.6% of SMPs reported that their reason for SM was fear of infection from health care units. This could be explained by the possibility that a lack of information regarding the COVID-19 disease may have evoked people’s worries and fears of catching it [8, 58, 59]. More than one-third (38.2%) of participants who consumed medicines thought that SM practice would protect them from COVID-19. Other causes of SM in the present study were urgency of the condition (47.2%), prior commitments and lack of time (33%), cost of the consultation (23.9%), and transport unavailability (10%). These reasons were consistent with those of previous studies [50, 54, 58].

The usage of certain drugs is consistent with COVID-19 symptoms; fever relief (65.1%), vitamins (57.1%), and antitussives (47.6%) were the most common drugs during the COVID-19 surge after painkillers (86%). These results were similar to those of previous studies [44, 46, 54]. Surprisingly, the reported SM practice not only included over-the-counter drugs but also prescribed drugs, specifically antibiotics (43.3%). This raises concerns as drug-resistant deaths are of considerable numbers, not to mention the economic burden in treating these cases [60].

In this study, the most frequent sources of information were pharmacist consultation (66.7%), academic knowledge (50.1%), and prior prescriptions for them (50.1). Previous studies agreed with our results [50, 61,62,63,64]. Hence, pharmacists play a key role in directing the population to appropriate SM [65]. However, some pharmacists seek profits, and their practice leads to inappropriate SM [66]. Strict policies and regulations should be applied to avoid these unethical behaviors.

The present data showed a significant increase in SM practice with increasing age, as reported earlier in Jordan, China, Nigeria, and Peru [7, 67,68,69,70,71]. This finding can be explained by the fact that elderly individuals tend to take care of their health to avoid aging-related diseases [69]. Some studies disagreed with these results and showed that SM practice was more common in younger individuals [72, 73]. Similar to Albawani, S. M. et al., we found that SM was not significantly associated with gender (male/female) or residence (urban/rural) [62]. However, these findings were in contrast with earlier studies [74,75,76,77,78,79,80].

Regarding the univariate logistic regression, we detected low odds of SM practice with preuniversity (p = 0.005), university (p = 0.003), and a high level of education (p = 0.008). This may be due to the raised awareness among educated participants about the threats of inappropriate use of drugs; most of the participants were related to the medical field (42.1%) [77]. Amuzie, C. I. et al. showed a significant association between SM frequency and those who did not attain university education compared to those who did [69].

Government employees and freelancers were more prone to self-medication than other occupations. This may be due to the idea of visiting a doctor being time-consuming [74]. The current data showed that time commitments were the reason for SM for 33% of the self-medicated participants. Having no medical insurance was another reason reported by 69.79% of respondents. This might explain why they tended to self-medicate. In contrast, a study conducted in Ethiopia reported lower self-medication practices among governmental employees [72]. The authors observed low odds of SM among the nonworking and retired groups. The cause may be the low income to purchase medications [67]. Our results indicated that SM is significantly associated with having monthly income and medical insurance but did not cover the treatment cost. This was inconsistent with the findings of Shafie, Mensur et al., who showed high SM practices among the high-income group [56].

The findings of this study inform Arab healthcare policymakers about the status of self-medication in the Arab region. Hence, this may encourage the development of policies and regulations to control the inappropriate use of medications. Additionally, since pharmacists play an important role in informing people about SM, we recommend developing educational curricula for pharmacists that focus on the ethics of drug supply, holding frequent seminars to discuss these challenges, and posting professional ethics charts in pharmacies. Furthermore, health ministries should conduct frequent public awareness campaigns to educate the public about the negative impacts of medication misuse, to provide reliable sources of information about medications and to give advice on the appropriate use of nonprescribed medications.

The main strength of this study is the large sample size across ten countries with different sociodemographic data. The general population is another strength instead of previous studies that included specific populations: medical students, undergraduates, or elderly individuals. Hence, this wider scope helped in exploring the pattern of SM across a diverse variety of populations. Regarding the limitations, we did not add 10% to the sample size to cover the decrease in response. Additionally, selection bias was a possibility because only those with access to internet-connected smart devices could respond to the questionnaire. However, the authors allowed offline data collection in the countries with ethical approval. The convenience sampling strategy is also one of the limitations. Additionally, the estimated SM practice was from the start of the pandemic, which might lead to recall bias. We recommend further studies to assess awareness about SM and any associated health hazards in the Middle East.


Due to the easy accessibility of drugs and the increased influence of social media during the COVID-19 pandemic, it became easier to practice SM inappropriately. The SM prevalence was slightly high during the COVID-19 pandemic. The most commonly used drugs were pain killers and fever-related medications. This made sense with the reported most frequent conditions, such as headache, common cold, and flu-like symptoms. Experience with similar conditions was the most common reason for SM, while pharmacist consultation was the most frequent source of information about SM. This phenomenon can be combated by increasing the public’s awareness of SM and its hazards, encouraging its wise use, promoting its rational consumption, and developing policies to restrict access to drugs other than over-the-counter drugs (OTCs).

Availability of data and materials

All data generated during this study are included in this published article and the additional file.



Over the Counter




Self-Medicated Participants


World Health Organization


  1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. Brief Report: A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727 [cited 2022]. Available from:/pmc/articles/PMC7092803/.

    Article  CAS  Google Scholar 

  2. Khan G, Sheek-Hussein M, Al Suwaidi A, Idris K, Abu-Zidan F. Novel coronavirus pandemic: A global health threat. Turkish J Emerg Med. 2020;20(2):55 [cited 2022]. Available from:/pmc/articles/PMC7305662/.

    Article  Google Scholar 

  3. Matta S, Chopra KK, Arora VK. Morbidity and mortality trends of Covid 19 in top 10 countries. Indian J Tuberc. 2020;67(4):S167 [cited 2022]. Available from:/pmc/articles/PMC7543896/.

    Article  Google Scholar 

  4. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. [cited 2022]. Available from:

  5. Makowska M, Boguszewski R, Nowakowski M, Podkowińska M. Self-medication-related behaviors and Poland’s COVID-19 lockdown. Int J Environ Res Public Health [Internet]. 2020;17(22):1–19 [cited 2022]. Available from:/pmc/articles/PMC7696561/.

    Google Scholar 

  6. Al-Tammemi A'a B, Tarhini Z. Beyond equity: Advocating theory-based health promotion in parallel with COVID-19 mass vaccination campaigns. Public health in practice (Oxford, England). 2021;2:100142.

    Article  Google Scholar 

  7. Elayeh E, Akour A, Haddadin RN. Prevalence and predictors of self-medication drugs to prevent or treat COVID-19: Experience from a Middle Eastern country. Int J Clin Pract. 2021;75(11) [cited 2022]. Available from:/pmc/articles/PMC8646359/.

  8. Quincho-Lopez A, Benites-Ibarra CA, Hilario-Gomez MM, Quijano-Escate R, Taype-Rondan A. Self-medication practices to prevent or manage COVID-19: A systematic review. PLoS One. 2021;16(11):e0259317 [cited 2022]. Available from:/pmc/articles/PMC8562851/.

    Article  CAS  Google Scholar 

  9. Hashmi FK, Atif N, Malik UR, Riboua Z, Saleem F, Khan YH, et al. Misinformation in Wake of the COVID-19 Outbreak: Fueling Shortage and Misuse of Lifesaving Drugs in Pakistan. Disaster Med Public Health Prep. 2021;15(4):1 [cited 2022 Jul]. Available from:/pmc/articles/PMC7783134/.

    Article  Google Scholar 

  10. World Health Organization. Guidelines for the regulatory assessment of medicinal products for use in self-medication. World Health Organization. 2000.

  11. Balbuena FR, Aranda AB, Figueras A. Self-Medication in Older Urban Mexicans. Drugs Aging. 2012;26(1):51–60 [cited 2022]. Available from:

    Article  Google Scholar 

  12. Kasulkar AA, Gupta M. Self medication practices among medical students of a private institute. Indian J Pharm Sci. 2015;77(2):178–82 [cited 2022] Available from:

    Article  Google Scholar 

  13. Arrais PSD, Fernandes MEP, da Silva Dal Pizzol T, Ramos LR, Mengue SS, Luiza VL, et al. Prevalence of self-medication in Brazil and associated factors. Rev Saude Publica [Internet]. 2016;50(suppl 2) [cited 2022] Available from:

  14. Håkonsen H, Sundell KA, Martinsson J, Hedenrud T. Consumer preferences for over-the-counter drug retailers in the reregulated Swedish pharmacy market. Health Policy. 2016;120(3):327–33 [cited 2022]. Available from:

    Article  Google Scholar 

  15. do Prado MAMB, Francisco PMSB, Bastos TF, de Azevedo Barros MB. Use of prescription drugs and self-medication among men. Rev Bras Epidemiol. 2016;19(3):594–608 [cited 2022]. Available from:

    Article  Google Scholar 

  16. Gama ASM, Secoli SR. Self-medication among nursing students in the state of Amazonas - Brazil. Rev Gauch Enferm. 2017;38(1):e65111 [cited 2022]. Available from:

    Google Scholar 

  17. Helal RM, Abou-Elwafa HS. Self-medication in university students from the City of Mansoura, Egypt. J Environ Public Health. 2017;2017 [cited 2022]. Available from:

  18. Abdi A, Faraji A, Dehghan F, Khatony A. Prevalence of self-medication practice among health sciences students in Kermanshah, Iran. BMC Pharmacol Toxicol. 2018;19(1) [cited 2022]. Available from:

  19. Kassie AD, Bifftu BB, Mekonnen HS. Self-medication practice and associated factors among adult household members in Meket district, Northeast Ethiopia, 2017. BMC Pharmacol Toxicol. 2018;19(1) [cited 2022]. Available from:

  20. Lei X, Jiang H, Liu C, Ferrier A, Mugavin J. Self-Medication Practice and Associated Factors among Residents in Wuhan, China. Int J Environ Res Public Health. 2018;15(1) [cited 2022]. Available from:

  21. Onchonga D. A Google trends study on the interest in self-medication during the 2019 novel coronavirus (COVID-19) disease pandemic. Saudi Pharm J. 2020;28(7):903 [cited 2022]. Available from:/pmc/articles/PMC7299852/.

    Article  CAS  Google Scholar 

  22. Bennadi D. Self-medication: A current challenge. J Basic Clin Pharm. 2013;5(1):19 [cited 2022]. Available from:/pmc/articles/PMC4012703/.

    Article  Google Scholar 

  23. Hughes CM, McElnay JC, Fleming GF. Benefits and Risks of Self Medication. Drug Saf. 2001;24(14):1027–37 [cited 2022]. Available from:

    Article  CAS  Google Scholar 

  24. Noone J, Blanchette CM. The value of self-medication: summary of existing evidence. J Med Econ. 2018;21(2):201–11 [cited 2022]. Available from:

    Article  Google Scholar 

  25. Hughes CM, McElnay JC, Fleming GF. Benefits and risks of self-medication. Drug Saf. 2001;24(14):1027–37 [cited 2022]. Available from:

    Article  CAS  Google Scholar 

  26. Foy JM, Earls MF. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Pediatrics. 2005;115(1):e97–104.

    Article  Google Scholar 

  27. Lamy PP. Hazards of drug use in elderly individuals. Commonsense measures to reduce them. Postgrad Med. 1984;76(1):50–61.

    Article  CAS  Google Scholar 

  28. Drugs in the home: danger and waste [Internet]. [cited 2022]. Available from:

  29. Conn VS. Self-management of over-the-counter medications by older adults. Public Health Nurs. 1992;9(1):29–36 [cited 2022]. Available from:

    Article  CAS  Google Scholar 

  30. Afridi MI, Rasool G, Tabassum R, Shaheen M, Siddiqullah SM. Prevalence and pattern of self-medication in Karachi: A community survey. Pakistan J Med Sci. 2015;31(5):1241 [cited 2022]. Available from:/pmc/articles/PMC4641291/.

    Google Scholar 

  31. Malik M, Tahir MJ, Jabbar R, Ahmed A, Hussain R. Self-medication during Covid-19 pandemic: challenges and opportunities. Drugs Ther Perspect. 2020;36(12):565–7 [cited 2022]. Available from:

    Article  Google Scholar 

  32. Guzmán AF, Caamano F, Gestal-Otero JJ. Sociodemographic factors related to self-medication in Spain. Eur J Epidemiol. 2000;16(1):19–26 [cited 2022]. Available from:

    Article  Google Scholar 

  33. Martins AP, Da Costa MA, Mendes Z, Soares MA, Ferreira P, Nogueira A. Self-medication in a Portuguese urban population: a prevalence study. Pharmacoepidemiol Drug Saf. 2002;11(5):409–14 [cited 2022]. Available from:

    Article  Google Scholar 

  34. Content of home pharmacies and self-medication practices in households of pharmacy and medical students in Zagreb, Croatia: findings in 2001 with a reference to 1977 - PubMed [Internet]. [cited 2022]. Available from:

  35. Hallas J, Jensen KB, Grodum E, Damsbo N, Gram LF. Drug-related admissions to a department of medical gastroenterology. The role of self-medicated and prescribed drugs. Scand J Gastroenterol. 1991;26(2):174–80 [cited 2022]. Available from:

    Article  CAS  Google Scholar 

  36. Common patient symptoms: patterns of self-treatment and prevention - PubMed [Internet]. [cited 2022]. Available from:

  37. Mensah BN, Agyemang IB, Afriyie DK, Amponsah SK. Self-medication practice in Akuse, a rural setting in Ghana. Niger Postgrad Med J. 2019;26(3):189 [cited 2022] Available from:;year=2019;volume=26;issue=3;spage=189;epage=194;aulast=Mensah.

    Article  Google Scholar 

  38. JPMA - Journal Of Pakistan Medical Association [Internet]. [cited 2022]. Available from:

  39. Shah K, Halder S, Haider SS. Assessment of knowledge, perception, and awareness about self-medication practices among university students in Nepal. Heliyon. 2021;7(1) [cited 2022]. Available from:/pmc/articles/PMC7815801/.

  40. Hashemzaei M, Afshari M, Koohkan Z, Bazi A, Rezaee R, Tabrizian K. Knowledge, attitude, and practice of pharmacy and medical students regarding self-medication, a study in Zabol University of Medical Sciences; Sistan and Baluchestan province in south-east of Iran. BMC Med Educ. 2021;21(1) [cited 2022]. Available from:/pmc/articles/PMC7807440/.

  41. Ruiz M. Risks of Self-medication practices. Curr Drug Saf. 2010;5(4):315–23.

    Article  Google Scholar 

  42. Hasan S, Al-Omar MJ, AlZubaidy H, Al-Worafi YM. Use of Medications in Arab Countries. Handb Healthc Arab World. 2019:1–42 [cited 2022]. Available from:

  43. Khalifeh MM, Moore ND, Salameh PR. Self-medication misuse in the Middle East: a systematic literature review. Pharmacol Res Perspect. 2017;5(4):323 [cited 2022]. Available from:/pmc/articles/PMC5684864/.

    Article  Google Scholar 

  44. Suarez-Lledo V, Alvarez-Galvez J. Prevalence of Health Misinformation on Social Media: Systematic Review. J Med Internet Res. 2021;23(1) [cited 2022]. Available from:/pmc/articles/PMC7857950/.

  45. Yasmin F, Asghar MS, Naeem U, Najeeb H, Nauman H, Ahsan MN, et al. Self-medication practices in medical students during the COVID-19 pandemic: A cross-sectional analysis. Front Public Heal. 2022;10:389.

    Google Scholar 

  46. Mansuri FMA, Zalat MM, Khan AA, Alsaedi EQ, Ibrahim HM. Estimating the public response to mitigation measures and self-perceived behaviours towards the COVID-19 pandemic. J Taibah Univ Med Sci. 2020;15(4):278 [cited 2022] Available from:/pmc/articles/PMC7334963/.

    Google Scholar 

  47. Ibrahim DA, Halboup A. Self-medication practice among health sciences undergraduate students in Sana’a City-Yemen. Int J Pharm Investig. 2019;9(2):80–4.

    Article  Google Scholar 

  48. Salih M, Abd A. Self-medication survey among pharmacy students in Iraq. J Pharm Bioallied Sci. 2021;13(3):291 [cited 2022]. Available from:/pmc/articles/PMC8698082/.

    Article  Google Scholar 

  49. Sadio AJ, Gbeasor-Komlanvi FA, Konu RY, Bakoubayi AW, Tchankoni MK, Bitty-Anderson AM, et al. Assessment of self-medication practices in the context of the COVID-19 outbreak in Togo. BMC Public Health. 2022;21(1):1–9 [cited 2022]. Available from:

    Google Scholar 

  50. Wegbom AI, Edet CK, Raimi O, Fagbamigbe AF, Kiri VA. Self-Medication Practices and Associated Factors in the Prevention and/or Treatment of COVID-19 Virus: A Population-Based Survey in Nigeria. Front Public Heal. 2021;9:606801 [cited 2022]. Available from:/pmc/articles/PMC8213209/.

    Article  Google Scholar 

  51. Dare SS, Eze ED, Isaac E, Usman IM, Ssempijja F, Bukenya EE, et al. COVID-19 Pandemic and Behavioural Response to Self-Medication Practice in Western Uganda. medRxiv. 2021; [cited 2022]. Available from:

  52. Chopra D, Bhandari B, Sidhu JK, Jakhar K, Jamil F, Gupta R. Prevalence of self-reported anxiety and self-medication among upper and middle socioeconomic strata amidst COVID-19 pandemic. J Educ Health Promot. 2021;10(1):73 [cited 2022]. Available from:/pmc/articles/PMC8057176/.

    Article  Google Scholar 

  53. Azhar H, Tauseef A, Usman T, Azhar Y, Ahmed M, Umer K, et al. Prevalence, attitude and knowledge of self medication during covid-19 disease pandemic. Pakistan J Med Health Sci. 2021;15(5). [cited 2022]. Available from.

  54. Sisay M, Mengistu G, Edessa D. Epidemiology of self-medication in Ethiopia: A systematic review and meta-analysis of observational studies. BMC Pharmacol Toxicol. 2018;19(1):1–12 [cited 2022]. Available from:

    Article  Google Scholar 

  55. Varpaei HA. Assessing the relationship between self-medication and chronic condition self-medication: analytic-descriptive study.

  56. Shafie M, Eyasu M, Muzeyin K, Worku Y, Martín-Aragón S. Prevalence and determinants of self-medication practice among selected households in Addis Ababa community. PLoS One. 2018;13(3) [cited 2022]. Available from:/pmc/articles/PMC5868796/.

  57. Lei X, Jiang H, Liu C, Ferrier A, Mugavin J. Self-Medication Practice and Associated Factors among Residents in Wuhan, China. Int J Environ Res Public Health. 2018;15(1) [cited 2022]. Available from:/pmc/articles/PMC5800167/.

  58. Coelho CM, Suttiwan P, Arato N, Zsido AN. On the nature of fear and anxiety triggered by COVID-19. Front Psychol. 2020;11:3109.

    Article  Google Scholar 

  59. Quadros S, Garg S, Ranjan R, Vijayasarathi G, Mamun MA. Fear of COVID 19 infection across different cohorts: A scoping review. Front Psychiatry. 2021;12:1289.

    Article  Google Scholar 

  60. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55 [cited 2022]. Available from:

    Article  CAS  Google Scholar 

  61. Mojali S, Al-Ghanim S, Alduais AM, F. Al-Shabrani B. Self-medication practice among Yemeni patients in Ibb city: a survey study exploring patients’ perceptives. J Hosp Adm. 2015;4(4):32.

    Google Scholar 

  62. Abdelwahed RNK, Jassem M, Alyousbashi A. Self-medication practices, prevalence and associated factors among Syrian adult patients: a cross-sectional study; 2022 [cited 2022]. Available from.

    Book  Google Scholar 

  63. Albawani SM, Bin HY, Abd-Aziz N, Gnanasan S. Self-medication with antibiotics in sana’a city, Yemen. Trop. J Pharm Res. 2017;16(5):1195–9.

    Google Scholar 

  64. Al-Qahtani AM, Shaikh IA, Shaikh MAK, Mannasaheb BA, Al-Qahtani FS. Prevalence, Perception, and Practice, and Attitudes Towards Self-Medication Among Undergraduate Medical Students of Najran University, Saudi Arabia: A Cross-Sectional Study. Risk Manag Healthc Policy. 2022;15:257 [cited 2022]. Available from:/pmc/articles/PMC8859296/.

    Article  Google Scholar 

  65. Akour A, Elayeh E, Tubeileh R, Hammad A, Ya’Acoub R, Al-Tammemi AB. Role of community pharmacists in medication management during COVID-19 lockdown. Pathog Glob Health. 2021;115(3):168 [cited 2022]. Available from:/pmc/articles/PMC8079017/.

    Article  CAS  Google Scholar 

  66. Hamid H, Masood RA, Tariq H, Khalid W, Rashid MA, Munir MU. Current pharmacy practices in low- and middle-income countries; recommendations in response to the COVID-19 pandemic. Drugs Ther Perspect. 2020;36(8):355 [cited 2022]. Available from:/pmc/articles/PMC7245645/.

    Article  Google Scholar 

  67. Selvaraj K, Kumar Ganesh S, Ramalingam A. Prevalence of self-medication practices and its associated factors in Urban Puducherry, India. Perspect Clin Res. 2014;5(1):32 [cited 2022]. Available from:;year=2014;volume=5;issue=1;spage=32;epage=36;aulast=Selvaraj.

    Article  Google Scholar 

  68. Nasir M, Chowdhury ASMS, Zahan T. Self-medication during COVID-19 outbreak: a cross sectional online survey in Dhaka city. Int J Basic Clin Pharmacol. 2020;9(9):1325.

    Article  Google Scholar 

  69. Amuzie CI, Kalu KU, Izuka M, Nwamoh UN, Emma-Ukaegbu U, Odini F, et al. Prevalence, pattern and predictors of self-medication for COVID-19 among residents in Umuahia, Abia state, Southeast Nigeria: policy and public health implications. J Pharm Policy Pract. 2022;15(1):1–9 [cited 2022]. Available from:

    Article  Google Scholar 

  70. Pan H, Cui B, Zhang D, Farrar J, Law F, Ba-Thein W. Prior knowledge, older age, and higher allowance are risk factors for Self-medication with antibiotics among university students in southern China. PLoS One. 2012;7(7) [cited 2022]. Available from:/pmc/articles/PMC3401104/.

  71. Quispe-Cañari JF, Fidel-Rosales E, Manrique D, Mascaró-Zan J, Huamán-Castillón KM, Chamorro-Espinoza SE, et al. Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey. Saudi Pharm J. 2021;29(1):1 [cited 2022]. Available from:/pmc/articles/PMC7832015/.

    Article  Google Scholar 

  72. Tekeba A, Ayele Y, Negash B, Gashaw T. Extent of and Factors Associated with Self-Medication among Clients Visiting Community Pharmacies in the Era of COVID-19: Does It Relieve the Possible Impact of the Pandemic on the Health-Care System? Risk Manag Healthc Policy. 2021;14:4939 [cited 2022]. Available from:/pmc/articles/PMC8683580/.

    Article  Google Scholar 

  73. Domingues PHF, Galvão TF, de Andrade KRC, Araújo PC, Silva MT, Pereira MG. Prevalence and associated factors of self-medication in adults living in the Federal District, Brazil: a cross-sectional, population-based study*. Epidemiol e Serviços Saúde. 2017;26(2):319–30 [cited 2022]. Available from:

    Article  Google Scholar 

  74. Chapagain K, Rauniyar GP. Self-medication Practices among the Peri-urban Households of Two Communities of Dharan Submetropolitan city of Eastern Nepal: A Descriptive Cross-sectional Study. J Nepal Med Assoc. 2020;58(228):569 [cited 2022]. Available from:/pmc/articles/PMC7580369/.

    Article  Google Scholar 

  75. Rangari GM, Bhaisare RG, Korukonda V, Chaitanya YL, Hanumanth N. Prevalence of self-medication in rural area of Andhra Pradesh. J Fam Med Prim Care. 2020;9(6):2891 [cited 2022]. Available from:/pmc/articles/PMC7491850/.

    Article  Google Scholar 

  76. Alshammari F, Alobaida A, Alshammari A, Alharbi A, Alrashidi A, Almansour A, et al. University students’ Self-medication practices and pharmacists’ role: A cross-sectional survey in hail, Saudi Arabia. Front Public Heal. 2021;9:2083.

    Google Scholar 

  77. Mohammed NA, Hamed AF, Kresha SAA. Self-medication and associated factors in Sohag governorate. J High Inst Public Heal. 2022;52(1):1–7.

    Google Scholar 

  78. Mekuria AB, Birru EM, Tesfa MT, Geta M, Kifle ZD, Amare T. Prevalence and predictors of Self-medication practice among teachers’ education training college students in Amhara region, Ethiopia: A cross-sectional study. Front Pharmacol. 2021;11:2457.

    Article  Google Scholar 

  79. Mannasaheb BA, Alajlan SA, Alshahrani JA, Othman N, Alolayan SO, Alamrah MS, et al. Prevalence, predictors and point of view toward Self-medication among residents of Riyadh, Saudi Arabia: A cross-sectional study. Front Public Heal. 2022;10:488.

    Google Scholar 

  80. Onchonga D, Omwoyo J, Nyamamba D. Assessing the prevalence of self-medication among healthcare workers before and during the 2019 SARS-CoV-2 (COVID-19) pandemic in Kenya. Saudi Pharm J. 2020:1149–54. Available from:.

Download references


Throughout the study, we have a tremendous deal of assistance and support. We are grateful to Dr. Khadijah Angawian Assistant Professor of Public Health in the Department of Health Services and Hospital Administration at the Faculty of Economics and Administration, King Abdulaziz University, Jeddah, Saudi Arabia, Dr. Fatime Elsheikh Mohammed Al-Hadi, an assistant Professor at Saudi Electronic University with a Ph.D. degree in public health and epidemiology, and Dr. Manar Ahmed Kamal, Faculty of Medicine, Benha University, Benha, Egypt for helping us assess the validity of the questionnaire. Additionally, they supplied us with comments and tips that improved the questionnaire and made it valid for data collection.

Additionally, we would like to thank Mayar El-Haddad, Waad Amur Salim Al Harthi, Mohamed nur rhil, Malek Talal, Jomana Akra, Rasheed A. Rasheed, Shimos Alsharref, Hazem Metwally Faragallah, Yousef M. Husseiny, Maroa Saad Aljaberi, Mohammed Omar hag Mousa, Mustafa Ahmad Abu Jayyab, Fatimah Saad Elkhafeefi, Taima Qandeel, Djad Ghezal, and Mohammed Baqer Al-Jubouri for helping in the data collection process.

Finally, this work would not have been completed without the great effort of the collaborators group who helped in the data collection process from the included countries.

Collaborators group:

Jaafar D. Al-Dabagh 4, Ali R. Abdulabbas 5, Mohammed A.A. Osman 1, Mazen m.o. barakat 1, Maya M. Abdelwahab 6, Israa Al-fayyadh 7, Tharaa Khairy 8, Mabrouka salmi 9, Asmaa R. A. Elsokary 10, Tayba Mugibel 11, Batool A.A.Abuelsamen 12, Mostafa M.Naguib 13, Yassen M. Alothman 14, Omar Q. Heih 8, Ramadan A. Farahat 1, Imene Maallem 15, Nagy N. Mohamed 16, Areej M. Al-Mamari 17, Fatima H. Bin Yahya 18, Maryam O. Al Amodi 18, Ghada A. El-Shafey19, Esra E. Elkhoja 20, Salma A. Shawky 1, Salma Saleh 21, Fawzy Shendy 1, Tharaa Tobba22, Omar T. Elnewishy 23, Tima Al Shammaa 24, Wisam M. Alismaeil 14, Aiman S. Gmzawi 25, Rama N. Basheer 8, Bashar H. Hassan 26, Eman S. Barhoom 11, Areej Abumazen 8, Majd AL-lala7, Maathir I. Al farsi 17, Lujain B.S. laik 27, Muath M. Mohammed 1, Noof K. B. Abo Baker11, Marwan E. Mohamed 1, Hassan F. H. Elsayed 28, Waad N. Almanaseer 7, Yasmine R. Albalushi29, Hawwa Altaeb 20, Reem J. Husseiny 23, Mohammed Orief 1, Fatima Alaidaros 18, Hajar Fawzy 27, and Moh.Mah.Fadelallah Eljack 30 .


4 Faculty of Medicine, Baghdad University, Baghdad, Iraq.

5 Faculty of Medicine, Jabir Ibn Hayyan Medical University, Najaf, Iraq.

6 Faculty of Medicine, Helwan University, Cairo, Egypt.

7 Faculty of Medicine, Jordan University, Amman, Jordan.

8 Faculty of Medicine, Palestine Polytechnic University, Hebron, Palestine.

9 Applied Statistics, National School of Statistics and Applied Economics, Tipaza, Algeria.

10 Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

11 Faculty of Medicine, Hardhrmout University, Mukalla, Yemen.

12 Faculty of Medicine, Yarmouk University, Irbid, Jordan.

13 Faculty of Medicine, Al-Azhar University, Damietta, Egypt.

14 Faculty of Medicine, Idleb University, Idleb, Syria.

15Pharmacy department, Faculty of Medicine, Badji Mokhtar Annaba University, Algeria.

16Faculty of Science, Ain-shams University, Cairo, Egypt.

17 Faculty of Medicine, National University of science and technology, Sohar, Oman.

18 Faculty of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

19 Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.

20 Faculty of Medicine, Tripoli University, Tripoli, Libya.

21 Faculty of Medicine, Suez Canal University, Ismailia, Egypt.

22 Faculty of Medicine, Tishreen University, Lattakia, Syria.

23 Faculty of Medicine, Cairo University, Giza, Egypt.

24Queen’s University, Kingston, Ontario, Canada.

25Cardiology fellow in National Heart institute, Yemen.

26 Faculty of Medicine, Al Andalus University for Medical Sciences, Lattakia, Syria.

27Faculty of Medicine, Ain-shams University, Cairo, Egypt.

28 Faculty of Pharmacy, Sohag university, Sohag, Egypt.

29Faculty of Medicine, National University of science and technology, Muscat, Oman.

30University of Bakht Alruda, Sudan.


Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). The authors declare that this study was not funded.

Author information

Authors and Affiliations




AEA: Created and validated the idea, organized the study, participated in questionnaire preparation validation and reliability, and took part in data collection, entry, analysis, and manuscript writing (discussion) and editing of the full manuscript. MMA: Participated in idea validation, questionnaire preparation, validation, and reliability, and took part in data entry, analysis, and manuscript writing (abstract, method, and part of discussion) and editing the full manuscript. AEM: Participated in idea validation, questionnaire preparation, validation, and reliability, and took part in data entry, analysis, manuscript writing (introduction and abstract), and editing of the full manuscript. MOA: Participated in idea validation, questionnaire preparation, validation, and reliability, and took part in data collection organization, data entry, manuscript writing (introduction), and editing the full manuscript. MK: Participated in idea validation, questionnaire preparation, and reliability, and took part in data collection organization, data entry, and manuscript writing (results). AGE: Participated in idea validation, questionnaire preparation, and reliability, and took part in data collection organization, entry, and manuscript writing (results). MRH: Participated in idea validation, questionnaire preparation, and reliability, and took part in data collection organization, data entry, and manuscript writing (conclusion). RAI: Participated in idea validation, questionnaire preparation, validation, and reliability, and took part in data collection organization, and data entry. MMG: Participated in editing the last version of the manuscript. Cg: Participated in data generation, and the questionnaire reliability. NH: Supervisor in this study guided the other authors in statistical planning, helped in data analysis, and edited the last version of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Aya Elsayed Abdelwahed.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the ethical committees from the Faculty of Medicine at Kafrelsheikh University in Egypt (MKSU 2-2-2021), Palestine Polytechnic University in Palestine (KA/41/2021), College of medicine and health sciences at Hadramout University in Yemen (CM/REC/1/2021), école Nationale supérieure de Statistique et d’economie appliquée in Algeria (N 290/SDPF/2021), and College of Medicine at Bagdad University in Iraq (6257). All participants were aware of the study’s intentions and consented before responding. All of them were above 18 years old. They approved the statement of informed consent according to the Declaration of Helsinki after clarifying the study objectives before filling out the questionnaire (as shown Additional file 1).

The statement used for informed consent was “Filling out this questionnaire constitutes your consent to use your answers for research purposes only without revealing your identity or personal data, and you are free to withdraw at any time, without giving a reason and thank you”. All methods were performed in accordance with the relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdelwahed, A.E., Abd-elkader, M.M., Mahfouz, A. et al. Prevalence and influencing factors of self-medication during the COVID-19 pandemic in the Arab region: a multinational cross-sectional study. BMC Public Health 23, 180 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Self-medication
  • Arab
  • COVID-19
  • Drugs
  • Coronavirus
  • Antibiotic